Tomáš Šimurda/LinkedIn
Jun 16, 2026, 13:49
Tomáš Šimurda: Fibromics Team Secures EHA Innovation Grant for Innovative Research
Tomáš Šimurda, Hematologist at National Center of Hemostasis and Thrombosis, University Lecturer at Jessenius Faculty of Medicine in Martin, shared a post on LinkedIn:
“Honored to receive the 2026 European Hematology Association (EHA) Innovation Grant.
This recognition reflects the strength of international collaboration within the Fibromics consortia together with Alessandro Casini, Giancarlo Castaman, Saskia Schols, and Maartje van den Biggelaar.
Grateful to EHA for supporting innovative research in hematology and to all colleagues and collaborators who contribute to this journey.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?